← LibraryThe Cartilage Guide

Case series · 2022

[Bioregulation therapy in the treatment of age-related osteoarthropathy of the temporomandibular joint.]

Serikov AA, Soldatova LN, Iordanishvili AK, Pavlova SG · Advances in Gerontology (Uspekhi Gerontologii)

Anecdotalcounts toward this tier

Bone density of the joint elements was lower in patients than in healthy controls and tracked disease severity; after a course of bioregulatory therapy the elderly group's severity index moved from severe to moderate.

Population
Male patients aged 35–74 with functional pathology of the temporomandibular joint, against a healthy control group
Intervention
A course of bioregulatory therapy within complex treatment
Comparator
Healthy subjects for the baseline density comparison; no untreated patient arm
Limitations
The indexed abstract does not name which bioregulator was used, give group sizes, or report numbers; uncontrolled for the treatment itself; Russian-language institute-linked journal.

Cited by

1 entry references this study

  • Sigumir

    PeptidesBioregulators

    ANECD.